Press Release: Global Cannabis Use Disorder Treatment Industry Set for Substantial Expansion, Envisaging a Valuation Surge to US$ 2.66 Billion by 2033 | FMI

3w
1m read
Summary

In a groundbreaking development, the Global Cannabis Use Disorder Treatment Industry is set to witness a robust growth trajectory, as highlighted in a recent report by Future Market Insights. Around half of this number were living with hepatitis C, 1.4 million were living with HIV, and 1.2 million were living with both. Projections indicate a remarkable Compound Annual Growth Rate (CAGR) of 4.9% from 2023 to 2033, signifying a period of substantial expansion. This positive momentum is indicative of a burgeoning demand for effective cannabis use disorder therapies. In addition, numerous clinical studies are underway to develop anti-dependence drugs, although the results at present appear quite limited.

Article Preview

In a groundbreaking development, the Global Cannabis Use Disorder Treatment Industry is set to witness a robust growth trajectory, as highlighted in a recent report by Future Market Insights. Projections indicate a remarkable Compound Annual Growth Rate (CAGR) of 4.9% from 2023 to 2033, signifying a period of substantial expansion.

The market, valued at US$ 1.57 billion in 2022, is anticipated to soar to US$ 1.65 billion by the end of FY 2023, showcasing an impressive Year-on-Year (Y-o-Y) increase of over 5%. This positive momentum is indicative of a...

Read the full article @ Cannabis Law Report